AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,404,400 | +3963.5% | 590,000 | +6696.5% | 0.16% | +7900.0% |
Q2 2020 | $133,000 | +75.0% | 8,681 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $76,000 | +15.2% | 8,681 | 0.0% | 0.00% | +100.0% |
Q4 2019 | $66,000 | -99.3% | 8,681 | -99.3% | 0.00% | -99.6% |
Q1 2018 | $9,447,000 | -51.8% | 1,295,841 | -45.8% | 0.26% | -59.2% |
Q4 2017 | $19,613,000 | -39.7% | 2,391,841 | -22.8% | 0.65% | +4.7% |
Q3 2017 | $32,530,000 | +106.4% | 3,098,010 | +116.8% | 0.62% | -21.7% |
Q2 2017 | $15,763,000 | +15.6% | 1,429,114 | +1.5% | 0.79% | +2.1% |
Q1 2017 | $13,632,000 | -5.5% | 1,408,240 | +1.4% | 0.78% | -24.3% |
Q4 2016 | $14,424,000 | – | 1,388,240 | – | 1.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 520,830 | $2,625,000 | 1.69% |
COWEN AND COMPANY, LLC | 1,905,990 | $9,606,000 | 1.57% |
Ghost Tree Capital, LLC | 825,000 | $4,158,000 | 1.20% |
GENDELL JEFFREY L | 1,115,211 | $5,621,000 | 1.18% |
Vivo Capital, LLC | 3,526,093 | $17,772,000 | 1.03% |
ACUTA CAPITAL PARTNERS, LLC | 705,218 | $3,554,000 | 0.96% |
RTW INVESTMENTS, LP | 5,366,705 | $27,048,000 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 2,840,669 | $14,317,000 | 0.50% |
Avoro Capital Advisors LLC | 4,200,000 | $21,168,000 | 0.30% |
HighVista Strategies LLC | 57,495 | $290,000 | 0.21% |